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Abstract 
Objective: Assess the distribution and incidence of female breast cancer in the United States in 
different races and regions of the United States. Methods: Collect and analyze CDC WONDER 
data from the Center for Disease and Control to see if there are varying rates of female breast 
cancer incidence between races and in different regions of the United States. Results: The results 
are expected to show a significant difference in female breast cancer incidence between races 
and a non-significant difference in female breast cancer incidence among different regions of the 
United States. 
Key Words: breast cancer, cancer incidence, race, racial disparities, United States regions, 
geographic distribution 
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Introduction/Literature Review  
Breast cancer incidence in white versus non-white women has been a topic of discussion for 
several decades. Non-white women have a higher mortality rate than do white women and there 
are some analyses that show there may be differences in types of breast tumors among women of 
different races.1 
While papers on breast cancer incidence rates and geographic distribution exists, few 
have assessed the distribution of rates between against multiple races in the years 2012 to 2016 
and fewer have looked at breast cancer incidence alone. A study done by Laden et al. in 1997 
found a slight increase in incidence rates of invasive breast cancer in women from California 
compared to other areas of the United States and no significant differences between the 
Northeast, the Midwest, and the South.2 In a 2017 publication, DeSantis et al. reported Non-
Hispanic Black women were unfairly burdened with the triple-negative breast cancer, an 
aggressive subtype with poor prognosis, compared to Non-Hispanic White women.3 
In the late 1990s and early 2000s, female breast cancer incidence was noted to be highest 
in White women, compared to African Americans, Asian Americans and Pacific Islanders, 
Hispanics/Latinas, and American Indians and Alaska Natives. Not only does breast cancer 
incidence vary by race, survival does as well. In the same study, relative survival from breast 
cancer in women was found to be consistently decreased in African American women compared 
to White women.4  
Every year in the United States, nearly a quarter of a million cases of breast cancer are 
diagnosed in women and about 41,000 die from the disease. While the overall rate of diagnosis 
has remained stagnant over the course of several years, the rate of incidence has increased for 
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African Americans and Asian Americans and Pacific Islanders. The deaths from breast cancer 
have slowly declined in recent years, however, breast cancer is still the second leading cause of 
cancer death among women overall and is the leading cause of death in Hispanic/Latina women.5 
To our knowledge, a study has not yet been conducted to analyze regional and racial 
differences in female breast cancer incidence. This study aims to analyze the geographic 
distribution of breast cancer incidences in American Indian, Asian/Pacific Islander, 
Black/African American, and White women to assess the potential of racial and regional 
disparity in female breast cancer incidence in the Northeast, Midwest, South, and West regions 
of the United States from the years 2012-2016. 
Figure 1. Census Regions in the United States6 
 
Hypothesis/Specific Aims/Research Questions 
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• Research Question 1: How did female breast cancer incidence vary among the states 
between 2012 to 2016?  
• Research Question 2: How did female breast cancer incidence vary among different 
regions of the United States between 2012 and 2016? 
• Research Question 3: How did female breast cancer incidence vary among race between 
2012 and 2016? 
• Research Question 4: How did the rate female breast cancer incidence vary between 
different races in each of the United States regions in the years 2012 to 2016? 
• Hypothesis: There are no significant differences in female breast cancer incidence 
between the regions of the United States, however, there are significant differences in 
female breast cancer incidence between the various races. 
Methods 
Data Collection 
The CDC WONDER7 (Wide-Ranging Online Data for Epidemiologic Research) data for this 
study was obtained through the United States Cancer Statistics (USCS) database, which is the 
official federal statistics on cancer incidence for the fifty US states and the District of Columbia. 
The Centers for Disease Control and Prevention (CDC) and the National Cancer Institute (NCI) 
produce the official United States Cancer Statistics together yearly. CDC WONDER is a publicly 
available database that provides demographic information including age group, sex, race, and US 
Census region. 
Data Context 
 Le 5 
 
Populations in this study exclusively included women in the United States. The counts of female 
breast cancer rates between the years 2012 and 2016 were taken from the CDC WONDER 
database7. The rates of female breast cancer were then separated by race (Asian or Pacific 
Islander, Black or African American, White, American Indian or Alaska Native, and White) as 
well as by US Census regions (Northeast, Midwest, South, and West) by the CDC WONDER 
database.  
Data Analysis 
The CDC WONDER data set was qualitatively and quantitatively analyzed in order to 
determine if there is a statistically significant difference of breast cancer rates according to race 
and US region. Crude rates were calculated to analyze how female breast cancer rates varied 
among the states between the years 2012 and 2016. The rate of breast cancer was calculated 
based on the numbers in the population. Higher rates in some states may be due to increased 
population. The Bonferroni Procedure is a multiple comparison test for use in statistical analysis. 
One-way ANOVA with a Bonferroni post hoc tests comparing multiple regions and crude rates 
were calculated and used to identify how female breast cancer rates varied among each of the 
four US regions: Northeast, Midwest, South, and West between the years 2012 and 2016. One-
way ANOVA with a Bonferroni post hoc test was also used to analyze how female breast cancer 
rates varied among races between 2012 and 2016.  
Results 
When separated by region, there were no statistically significant data showing differences in 
female breast cancer incidence rates (F3,178 = 0.562, p = 0.641). The crude rates for the US 
Census regions (Northeast, Midwest, South, and West) are given below in Table 1.  
 Le 6 
 
Data showed that the rate of breast cancer incidence varied widely and was statistically 
significant between each of the fifty states and the District of Columbia when separated by race 
(F3,178 = 116.234, p < 0.001). The sample size was 1,196,484 women and the overall crude rate 
for female breast cancer incidences per 100,000 in the population was 147.9. 
 
The minimum crude rate of 25.877 was found in American Indian or Alaskan Native women in 
the state of Tennessee, which belongs to the southern US Census region. The maximum crude 
rate found, 196.704, was found in White women in the state of Hawaii, which belongs to the 
western US Census region. The crude rates of female breast cancer incidence for each race in the 
US are found on Table 2. 
 
The mean and standard deviations for crude rate in each of the races in each US state and the 
District of Columbia were 104.395 and 45.083, respectively. The state with the lowest crude rate 
was Wyoming (west US census region) and the state with the highest crude rate was Hawaii 
(west US census region). The means and respective standard deviations of breast cancer rates for 
women of different races and in different regions of the United States are described in Table 3. 
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Table 3 shows that rates of female breast cancer in a single race did not vary significantly 
between each region. However, the rate of female breast cancer in White women are 
significantly more positive than that of each of the other races in this study. 
 
The study found that White women had higher rates and were more positively associated with 
breast cancer incidence than are American Indian or Alaska Native, Asian or Pacific Islander, 
and Black or African American women (p < 0.001). In addition, Black or African American 
women were more positively associated with higher rates of breast cancer than are American 
Indian or Alaska Native and Asian or Pacific Islander women (p < 0.001). There were no 
significant mean differences in the rate of breast cancer between American Indian or Alaska 
Native women and Asian or Pacific Islander women in the United States (p = 0.141). 
Discussion 
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As predicted in the study hypothesis, this study found there to be no significant differences in 
female breast cancer rates between the four different US Census regions. While a prior study by 
Garland et al. proposed that vitamin D and decreased exposure to ultraviolet sunlight plays a role 
in reducing breast cancer risk, placing certain geographical locations and populations at higher 
risk, those studies primarily focused on mortality rates, rather than incidence rates alone.8 Other 
studies that initially found differences in breast cancer rates using a similar census-based method, 
found that several risk factors contributed to the unequal distribution of breast cancer incidence. 
Once a multivariate adjustment was done, the rates of breast cancer incidences were not any 
different among the different locations.9 
The third research question in this study sought to identify differences in the rate of female 
breast cancer among races in the United States. Significant differences were found between 
some, but not all of the races. Mean significant differences, with a 95% confidence interval, in 
the rate of female breast cancer were found between White women and each of the other three 
races (American Indian or Alaska Native, Asian or Pacific Islander, and Black or African 
American) as well as between Black or African American women and each of the other three 
races. White women had higher rates of breast cancer than did their American Indian or Alaskan 
Native, Asian or Pacific Islander, or Black or African American counterparts. Black or African 
American women were associated with increased rates of breast cancer than American Indian or 
Alaska Native and Asian or Pacific Islander women.  
This fourth research question in this study aimed to identify if there were any significant 
differences in rate of female breast cancer between each of the US regions when divided between 
the races. For example, did breast cancer rate in Black or African American women in the South 
differ significantly from the breast cancer rate in Black or African American women in the 
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Midwest? The study found there to be no significant differences between the races among the 
regions. 
Previous studies have found that higher incidences of aggressive breast cancer phenotypes, 
higher tumor grade, and higher tumor growth index are more associated with the Black or 
African American population compared to the White population.10 Black or African American 
women were also found to be much more likely to have a diagnosis with poorer prognosis and 
lower five-year survival rate compared to White women.11  
Study Limitations 
The major limitations of this study were related to the use of aggregate data from the CDC 
WONDER data set. Using aggregate data proved to be a limitation to the study because it 
prevented researchers from being able to separate the data into individual cases and patients, 
which in turn prevented the ability to analyze possible factors that contributed to breast cancer 
incidence. Confounding factors that potentially contributed to US female breast cancer incidence 
included genetic predisposition, exercise, diet, smoking, alcohol, and past medical history 
including diabetes, hypertension, cardiovascular disease, and menopausal state. The study also 
failed to account for the Hispanic/Latina or Non-Hispanic/Latina ethnicity of participants. This 
was due to the fact that the aggregate CDC WONDER data set did not provide ethnic data in 
addition to the data provided pertaining to race. 
Future Directions 
The findings of this study bring awareness to the racial disparities that persist in modern 
medicine. Given the rate of breast cancer and its apparent preference to certain races, it is 
important to promote annual breast cancer screenings and provide information and education to 
 Le 10 
 
those in the population who are of higher risk. In addition, further studies can be done to include 
confounding factors and other variables to better understand the disparities that play a role in the 
rates of breast cancer incidence. 
Studies in the future can be modeled similar after this study and be applied to a smaller, more 
focused scale. Studies can analyze racial disparities pertaining to the rate of female breast cancer 
in specific states, specific cities, or even a specified community with different urban and rural 
communities. Future studies can also bring in more characteristics and factors than just race and 
location. Studies can consider Hispanic/Latina or Non-Hispanic/Latina ethnicity as well as 
consider age. In addition, if it is possible to use individual patient data, studies can identify and 
consider the roles of confounding factors like genetics, level of exercise, diet, and past medical 
history in female breast cancer incidence. Finally, future studies can consider the amount of 
breast cancer related deaths among races and regions, rather than focusing solely on the rate of 
female breast cancer, as this study does. 
Conclusion 
Overall, this study identifies important information regarding the rates of breast cancer in 
women in the United States. While there were no significant differences in the rate of female 
breast cancer found between women living in different regions of the United States from the 
years 2012 to 2016, significant differences were identified among women of different races. 
While the rate of breast cancer incidence is largely multifactorial, differences among races 
proved to be statistically significant. Future studies are needed to further evaluate confounding 
factors and its effects on the incidences in and deaths from female breast cancer.  
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